Several studies have reported that DUXAP10 is aberrantly expressed in numerous human cancers, such as HCC, BC, NSCLC, glioma, RCC, PTC, PCa, CML, OC, PC, GC, CRC, ESCC, and OSCC. This evidence concerns the gene DUXAP10 and pachyonychia congenita.